Latent Class Analysis Identifies Distinct Phenotypes of Primary Graft Dysfunction After Lung Transplantation

被引:47
|
作者
Shah, Rupal J. [1 ,2 ]
Diamond, Joshua M. [1 ,2 ]
Cantu, Edward [3 ]
Lee, James C. [1 ]
Lederer, David J. [4 ]
Lama, Vibha N. [5 ]
Orens, Jonathan [6 ]
Weinacker, Ann [7 ]
Wilkes, David S. [8 ]
Bhorade, Sangeeta [9 ]
Wile, Keith M. [10 ]
Ware, Lorraine B. [11 ]
Palmer, Scott M. [12 ]
Crespo, Maria [13 ]
Localio, A. Russell [2 ]
Demissie, Ejigayehu [2 ]
Kawut, Steven M. [1 ,2 ]
Bellamy, Scarlett L. [2 ]
Christie, Jason D. [1 ,2 ]
机构
[1] Univ Penn, Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Div Cardiovasc Surg, Philadelphia, PA 19104 USA
[4] Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY 10032 USA
[5] Univ Michigan, Div Pulm Allergy & Crit Care Med, Ann Arbor, MI 48109 USA
[6] Johns Hopkins Univ Hosp, Dept Med, Div Pulm Allergy & Crit Care Med, Baltimore, MD 21205 USA
[7] Stanford Univ, Dept Pulm & Crit Care, Palo Alto, CA 94304 USA
[8] Indiana Univ Sch Med, Div Pulm Allergy & Crit Care Med, Indianapolis, IN 46202 USA
[9] Univ Chicago, Div Pulm & Crit Care Med, Chicago, IL 60637 USA
[10] Univ Alabama Birmingham, Div Pulm & Crit Care Med, Birmingham, AL USA
[11] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA
[12] Duke Univ, Div Pulm Allergy & Crit Care Med, Raleigh, NC USA
[13] Univ Pittsburgh, Div Pulm Allergy & Crit Care, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
INTERNATIONAL-SOCIETY; ALLOGRAFT DYSFUNCTION; INJURY; HEART;
D O I
10.1378/chest.12-1480
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: There is significant heterogeneity within the primary graft dysfunction (PGD) syndrome. We aimed to identify distinct grade 3 PGD phenotypes based on severity of lung dysfunction and patterns of resolution. Methods: Subjects from the Lung Transplant Outcomes Group (LTOG) cohort study with grade 3 PGD within 72 h after transplantation were included. Latent class analysis (LCA) was used to statistically identify classes based on changes in PGD International Society for Heart & Lung Transplantation grade over time. Construct validity of the classes was assessed by testing for divergence of recipient, donor, and operative characteristics between classes. Predictive validity was assessed using time to death. Results: Of 1,255 subjects, 361 had grade 3 PGD within the first 72 h after transplantation. LCA identified three distinct phenotypes: (1) severe persistent dysfunction (class 1), (2) complete resolution of dysfunction within 72 h (class 2), and (3) attenuation, without complete resolution within 72 h (class 3). Increased use of cardiopulmonary bypass, greater RBC transfusion, and higher mean pulmonary artery pressure were associated with persistent PGD (class 1). Subjects in class 1 also had the greatest risk of death (hazard ratio, 2.39; 95% CI, 1.57-3.63; P < .001). Conclusions: There are distinct phenotypes of resolution of dysfunction within the severe PGD syndrome. Subjects with early resolution may represent a different mechanism of lung pathology, such as resolving pulmonary edema, whereas those with persistent POD may represent a more severe phenotype. Future studies aimed at PGD mechanism or treatment may focus on phenotypes based on resolution of graft dysfunction.
引用
收藏
页码:616 / 622
页数:7
相关论文
共 50 条
  • [31] Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation
    Somers, Jana
    Ruttens, David
    Verleden, Stijn E.
    Vandermeulen, Elly
    Piloni, Davide
    Wauters, Els
    Lambrechts, Diether
    Vos, Robin
    Verleden, Geert M.
    Vanaudenaerde, Bart
    van Raemdonck, Dirk E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (07): : 941 - 949
  • [32] How Would You Grade Our Progress in Primary Graft Dysfunction after Lung Transplantation?
    Neyrink, Arne
    Verleden, Geert M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (02) : 155 - 157
  • [33] Primary graft dysfunction in lung transplantation: still a thorn in the side of lung transplant
    Wong, Kwun Hung Max
    Hsin, Kuan Yew Michael
    JOURNAL OF THORACIC DISEASE, 2024, 16 (01) : 1 - 5
  • [34] Interobserver variability in the evaluation of primary graft dysfunction after lung transplantation: impact of radiological training and analysis of discordant cases
    Andrisani, Maria Carmela
    Vespro, Valentina
    Fusco, Stefano
    Palleschi, Alessandro
    Musso, Valeria
    Esposito, Andrea
    Coppola, Alessandra
    Spadafora, Pierino
    Damarco, Francesco
    Scaravilli, Vittorio
    Cortesi, Laura
    Scudeller, Luigia
    Larici, Anna Rita
    Carrafiello, Gianpaolo
    RADIOLOGIA MEDICA, 2022, 127 (02): : 145 - 153
  • [35] Neutrophil Extracellular Traps Are Pathogenic in Primary Graft Dysfunction after Lung Transplantation
    Sayah, David M.
    Mallavia, Benat
    Liu, Fengchun
    Ortiz-Munoz, Guadalupe
    Caudrillier, Axelle
    DerHovanessian, Ariss
    Ross, David J.
    Lynch, Joseph P., III
    Saggar, Rajan
    Ardehali, Abbas
    Ware, Lorraine B.
    Christie, Jason D.
    Belperio, John A.
    Looney, Mark R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (04) : 455 - 463
  • [36] Local complement activation is associated with primary graft dysfunction after lung transplantation
    Kulkarni, Hrishikesh S.
    Ramphal, Kristy
    Ma, Lina
    Brown, Melanie
    Oyster, Michelle
    Speckhart, Kaitlyn N.
    Takahashi, Tsuyoshi
    Byers, Derek E.
    Porteous, Mary K.
    Kalman, Laurel
    Hachem, Ramsey R.
    Rushefski, Melanie
    McPhatter, Ja'Nia
    Cano, Marlene
    Kreisel, Daniel
    Scavuzzo, Masina
    Mittler, Brigitte
    Cantu, Edward, III
    Pilely, Katrine
    Garred, Peter
    Christie, Jason D.
    Atkinson, John P.
    Gelman, Andrew E.
    Diamond, Joshua M.
    JCI INSIGHT, 2020, 5 (17)
  • [37] Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation
    Kaza, Vaidehi
    Zhu, Chengsong
    Feng, Leying
    Torres, Fernando
    Bollineni, Srinivas
    Mohanka, Manish
    Banga, Amit
    Joerns, John
    Mohanakumar, T.
    Terada, Lance S.
    Li, Quan-Zhen
    TRANSPLANT IMMUNOLOGY, 2020, 59
  • [38] Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation
    Cantu, Edward
    Shah, Rupal J.
    Lin, Wei
    Daye, Zhongyin J.
    Diamond, Joshua M.
    Suzuki, Yoshikazu
    Ellis, John H.
    Borders, Catherine F.
    Andah, Gerald A.
    Beduhn, Ben
    Meyer, Nuala J.
    Ruschefski, Melanie
    Aplenc, Richard
    Feng, Rui
    Christie, Jason D.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 149 (02): : 596 - 602
  • [39] Extracorporeal membrane oxygenation for grade 3 primary graft dysfunction after lung transplantation: Long-term outcomes
    Bellier, Jocelyn
    Lhommet, Pierre
    Bonnette, Pierre
    Puyo, Philippe
    Le Guen, Morgan
    Roux, Antoine
    Parquin, Francois
    Chapelier, Alain
    Sage, Edouard
    CLINICAL TRANSPLANTATION, 2019, 33 (03)
  • [40] Primary Graft Dysfunction (PGD) Following Lung Transplantation
    Shah, Rupal J.
    Diamond, Joshua M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 39 (02) : 148 - 154